BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26089291)

  • 1. The effect of renal sympathetic denervation on nocturnal dipping in patients with resistant hypertension; observational data from a tertiary referral centre in the Republic of Ireland.
    Tuohy ST; Kyvelou SG; Gleeson PJ; Daniels FB; Ryan LA; Lappin DW; O'Donnell MJ; Sharif F
    Ir J Med Sci; 2016 Aug; 185(3):635-641. PubMed ID: 26089291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endothelin-1 levels in patients with resistant hypertension: effects of renal sympathetic denervation.
    Petramala L; Olmati F; Mancone M; Concistré A; Galassi M; Marinelli C; Tonnarini G; Lucia P; Costi U; Iannucci G; Sardella G; Letizia C
    Ann Med; 2017 Aug; 49(5):396-403. PubMed ID: 28084122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B
    Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
    Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
    Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
    Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular ultrasound for renal sympathetic denervation in patients with therapy-resistant hypertension not responding to radiofrequency renal sympathetic denervation.
    Stiermaier T; Okon T; Fengler K; Mueller U; Hoellriegel R; Schuler G; Desch S; Lurz P
    EuroIntervention; 2016 Jun; 12(2):e282-9. PubMed ID: 27290688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?
    Chen S; Kiuchi MG; Schmidt B; Hoye NA; Acou WJ; Liu S; Chun KRJ; Pürerfellner H
    Herz; 2019 Aug; 44(5):412-418. PubMed ID: 29255910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
    Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
    Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation.
    Sesa-Ashton G; Carnagarin R; Nolde JM; Muente I; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
    J Hypertens; 2024 May; 42(5):922-927. PubMed ID: 38230602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal sympathetic denervation in uncontrolled arterial hypertension after successful repair for aortic coarctation.
    Lurz P; Okon T; Riede T; Wagner R; Schuler G; Daehnert I; Desch S
    Int J Cardiol; 2016 Jan; 202():322-7. PubMed ID: 26422021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term verification of functional and structural renal damage after renal sympathetic denervation.
    Dörr O; Liebetrau C; Möllmann H; Gaede L; Troidl C; Wiebe J; Renker M; Bauer T; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1298-303. PubMed ID: 26699846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.